131 related articles for article (PubMed ID: 37934148)
1. Aesthetic Outcome and Psychosexual Distress After Treatment for Vulvar High-Grade Squamous Intraepithelial Lesions.
Trutnovsky G; Holter M; Gold D; Kopera D; Deban J; Misut D; Aust S; Tamussino K; Greimel E
J Low Genit Tract Dis; 2024 Jan; 28(1):48-53. PubMed ID: 37934148
[TBL] [Abstract][Full Text] [Related]
2. Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.
Trutnovsky G; Reich O; Joura EA; Holter M; Ciresa-König A; Widschwendter A; Schauer C; Bogner G; Jan Z; Boandl A; Kalteis MS; Regauer S; Tamussino K
Lancet; 2022 May; 399(10337):1790-1798. PubMed ID: 35483400
[TBL] [Abstract][Full Text] [Related]
3. Medical interventions for high-grade vulval intraepithelial neoplasia.
Pepas L; Kaushik S; Nordin A; Bryant A; Lawrie TA
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007924. PubMed ID: 26284429
[TBL] [Abstract][Full Text] [Related]
4. Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial.
Terlou A; van Seters M; Ewing PC; Aaronson NK; Gundy CM; Heijmans-Antonissen C; Quint WG; Blok LJ; van Beurden M; Helmerhorst TJ
Gynecol Oncol; 2011 Apr; 121(1):157-62. PubMed ID: 21239049
[TBL] [Abstract][Full Text] [Related]
5. Treatment of vulvar intraepithelial neoplasia with topical imiquimod.
van Seters M; van Beurden M; ten Kate FJ; Beckmann I; Ewing PC; Eijkemans MJ; Kagie MJ; Meijer CJ; Aaronson NK; Kleinjan A; Heijmans-Antonissen C; Zijlstra FJ; Burger MP; Helmerhorst TJ
N Engl J Med; 2008 Apr; 358(14):1465-73. PubMed ID: 18385498
[TBL] [Abstract][Full Text] [Related]
6. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
Koeneman MM; Kruse AJ; Kooreman LFS; Zur Hausen A; Hopman AHN; Sep SJS; Van Gorp T; Slangen BFM; van Beekhuizen HJ; van de Sande M; Gerestein CG; Nijman HW; Kruitwagen RFPM
BMC Cancer; 2016 Feb; 16():132. PubMed ID: 26897518
[TBL] [Abstract][Full Text] [Related]
7. Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial.
Tristram A; Hurt CN; Madden T; Powell N; Man S; Hibbitts S; Dutton P; Jones S; Nordin AJ; Naik R; Fiander A; Griffiths G
Lancet Oncol; 2014 Nov; 15(12):1361-8. PubMed ID: 25304851
[TBL] [Abstract][Full Text] [Related]
8. Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
Fonseca BO; Possati-Resende JC; Salcedo MP; Schmeler KM; Accorsi GS; Fregnani JHTG; Antoniazzi M; Pantano NP; Santana IVV; Matsushita GM; Dos Reis R
Obstet Gynecol; 2021 Jun; 137(6):1043-1053. PubMed ID: 33957649
[TBL] [Abstract][Full Text] [Related]
9. The Paget Trial: topical 5% imiquimod cream for noninvasive vulvar Paget disease.
van der Linden M; van Hees CL; van Beurden M; Bulten J; van Dorst EB; Esajas MD; Meeuwis KA; Boll D; van Poelgeest MI; de Hullu JA
Am J Obstet Gynecol; 2022 Aug; 227(2):250.e1-250.e8. PubMed ID: 35447145
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot study.
van Seters M; Fons G; van Beurden M
J Reprod Med; 2002 Sep; 47(9):701-5. PubMed ID: 12380448
[TBL] [Abstract][Full Text] [Related]
11. Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence.
Wallbillich JJ; Rhodes HE; Milbourne AM; Munsell MF; Frumovitz M; Brown J; Trimble CL; Schmeler KM
Gynecol Oncol; 2012 Nov; 127(2):312-5. PubMed ID: 22867736
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
de Witte CJ; van de Sande AJ; van Beekhuizen HJ; Koeneman MM; Kruse AJ; Gerestein CG
Gynecol Oncol; 2015 Nov; 139(2):377-84. PubMed ID: 26335596
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%.
Diaz-Arrastia C; Arany I; Robazetti SC; Dinh TV; Gatalica Z; Tyring SK; Hannigan E
Clin Cancer Res; 2001 Oct; 7(10):3031-3. PubMed ID: 11595691
[TBL] [Abstract][Full Text] [Related]
14. Treatment of vulvar intraepithelial neoplasia with topical 5% imiquimod cream.
Westermann C; Fischer A; Clad A
Int J Gynaecol Obstet; 2013 Mar; 120(3):266-70. PubMed ID: 23219095
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod 5% cream versus cold knife excision for treatment of VIN 2/3: a five-year follow-up.
Frega A; Sesti F; Sopracordevole F; Biamonti A; Scirpa P; Milazzo GN; Catalano A; Assorgi C; Lombardi D; Gentile M; Maniglio P; Ricciardi E; Cozza G; Marziani R; Moscarini M
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(7):936-40. PubMed ID: 23640441
[TBL] [Abstract][Full Text] [Related]
16. Treatment of bowenoid and basaloid vulvar intraepithelial neoplasia 2/3 with imiquimod 5% cream.
Marchitelli C; Secco G; Perrotta M; Lugones L; Pesce R; Testa R
J Reprod Med; 2004 Nov; 49(11):876-82. PubMed ID: 15603097
[TBL] [Abstract][Full Text] [Related]
17. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.
Kesic V; Carcopino X; Preti M; Vieira-Baptista P; Bevilacqua F; Bornstein J; Chargari C; Cruickshank M; Erzeneoglu E; Gallio N; Gultekin M; Heller D; Joura E; Kyrgiou M; Madić T; Planchamp F; Regauer S; Reich O; Esat Temiz B; Woelber L; Zodzika J; Stockdale C
Int J Gynecol Cancer; 2023 Apr; 33(4):446-461. PubMed ID: 36958755
[TBL] [Abstract][Full Text] [Related]
18. Medical interventions for high grade vulval intraepithelial neoplasia.
Pepas L; Kaushik S; Bryant A; Nordin A; Dickinson HO
Cochrane Database Syst Rev; 2011 Apr; (4):CD007924. PubMed ID: 21491403
[TBL] [Abstract][Full Text] [Related]
19. TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
van de Sande AJM; Koeneman MM; Gerestein CG; Kruse AJ; van Kemenade FJ; van Beekhuizen HJ
BMC Cancer; 2018 Jun; 18(1):655. PubMed ID: 29902979
[TBL] [Abstract][Full Text] [Related]
20. A case of usual (basaloid)-type vulvar intraepithelial neoplasia that failed to respond to imiquimod cream: clinical implications.
Shiozaki T; Tabata T; Toriyabe K; Motohashi T; Kondo E; Tanida K; Okugawa T; Sagawa N
Int J Clin Oncol; 2011 Oct; 16(5):610-2. PubMed ID: 21249413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
